Diabetes and metabolic health Archive

People with type 2 diabetes or who have a high BMI with a metabolic risk factor (such as a large belly, abnormal lipid levels, or high blood pressure) should be screened for metabolic dysfunction-associated steatotic liver disease, a form of fatty liver disease.

For people with excess weight, type 2 diabetes, and heart disease, using the GLP-1 drug tirzepatide (Mounjaro, Zepbound) may lower the risk of heart attack, infection, and death from any cause more than taking an older drug, sitagliptin (Januvia), according to a 2026 study.

Social media influencers blame “high cortisol” for an array of problems, from stubborn belly fat to poor sleep. But true cortisol disorders are rare and most people have no evidence that abnormal cortisol levels are driving such problems.

My 50-year old son has developed bulging eyes over the last few months. It makes him look different, and I would like to know what may cause this.

An elevated GGT result can have several explanations, from supplements and pain relievers to underlying liver conditions.

A low sodium result can have several explanations, and the clues often come from your medications, fluid balance, and overall health.

People on levothyroxine sometimes notice trouble sleeping, raising concerns about how long it will persist and whether dose changes could improve rest.

GLP-1 drugs, such as semaglutide and tirzepatide, used for diabetes and weight loss, may also reduce knee osteoarthritis pain and delay knee replacement surgery. In a large 2026 study, the use of any GLP-1 was linked to a reduced likelihood of knee replacement over eight years.

Thyroid issues and blood pressure may be connected in more than one way. See how symptoms, lab results and treatment can affect your readings.

A rise in thyroid-stimulating hormone after thyroid removal can have several explanations, from medication timing to changes in absorption.